Browse by Medical Category
Accepting New Patients
Go To Programs
Go To Specialties
Digestive Healthcare Center
Go To Specialties
Dr. Keith D. Lillemoe received his undergraduate education at the University of South Dakota and his MD from The Johns Hopkins University School of Medicine in l978. He served his surgical training at Hopkins and joined the faculty there in l985, rising to the rank of Professor of Surgery in l996. He served as Associate Program Director for the Hopkins Surgical Residency from l993 to 2003 and Vice-Chairman of the department from l997 to 2003. He was recognized with the Hopkins Department of Surgery Faculty Teaching Award on five occasions. In 2003 he was appointed the Jay L Grosfeld Professor and Chairman of the Department of Surgery at the Indiana University School of Medicine. In May 2011, Dr Lillemoe was appointed to the position of Surgeon-in-Chief and Chief of the Department of Surgery at the Massachusetts General Hospital and the W Gerald Austen Professor of Surgery at the Harvard Medical School.Dr Lillemoe has served as Secretary, President and Chairman of the Board of Trustees of the Society for Surgery of the Alimentary Tract. He has served as President of the Society of Clinical Surgery, Secretary and President of the Society of University Surgeons, and as the Recorder for the American Surgical Association. He is a Senior Director of the American Board of Surgery. Dr. Lillemoe's clinical research interests are in pancreatic cancer, IPMNs and other benign pancreatic disorders, and biliary tract injuries. His bibliography lists over 300 journal articles and 115 book chapters. He has served as a visiting professor over 70 times and has spoken nationally and internationally on over 315 occasions. He is currently the Editor of one of the leading surgical texts Surgery: Scientific Principles and Practice and is Editor-in-Chief of Annals of Surgery.
Lillemoe KD: Current management of bile duct injury. Br J Surg 95:403-405, 2008.
Bilimoria KY, Bentrem DJ, Lillemoe KD, et al. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Nat Can Inst 101:848-859, 2009.
Ziegler KM, Nakeeb A, Pitt HA, Schmidt CM, Bishop SA, Moreno J, Matos JM, Zyromski NJ, House MG, Madura JA, Howard TJ, and Lillemoe KD: Pancreatic Surgery: Evolution at a high volume center. Surgery 148:702-710, 2010. (Presented at the Central Surgical Association, 2010).
Ziegler KM, Pitt HA, Zyromski NJ, Chauhan A, Sherman S, Lehman GA, Lillemoe KD,
Rescorla FJ, West KW, and Grosfeld JL: Choledochoceles: Are they choledochal cysts? Ann Surg 252:683-690, 2010. (Presented at the American Surgical Association, 2010).
Lutz E, Yeo CJ, Lillemoe KD, et al. A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma: A phase II trialof safety, efficacy, and immune activation. Ann Surg 253: 328-335, 2011.
Thirty-six former MGH patients, ranging in age from 35 to 81, recently returned to the hospital for the inaugural pancreatic surgery patient symposium, "Through Patients' Eyes: Understanding Life After Pancreatic Surgery."
Some virtuosos play the piano to perfection, others paint like Picasso, but for MGH physician-researchers, talent lies in the art of discovery.
Efforts at Massachusetts General Hospital Cancer Center are underway to address the need for more effective treatment approaches for locally advanced and metastatic disease.
The MGH Department of Surgery hosted Lord Ara Darzi of Denham, England, as the keynote speaker of the third annual Charles D. McCabe Lecture in Surgical Education Sept. 16.
Back to Top